Medicine and Dentistry
Ovarian Cancer
100%
DNA Repair
100%
Immunity
100%
Homologous Recombination
62%
PARP Inhibitor
50%
Immune Checkpoint Blockade
50%
Gene Mutation
25%
Immunotherapy
12%
Neoplasm
12%
Biological Marker
12%
Genomic Instability
12%
Cancer Therapy
12%
Lifespan
12%
Cancer Pathobiology
12%
Cancer Treatment
12%
Clinical Trial
12%
Tumor Progression
12%
Biochemistry, Genetics and Molecular Biology
DNA Repair
100%
Homologous Recombination
100%
Immunity
100%
Immune Checkpoints
80%
Poly ADP Ribose Polymerase
80%
Gene Mutation
40%
Genome Instability
20%
Lifespan
20%
Tumor Progression
20%
Clinical Trial
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
50%
Tumor Growth
12%
Immune Checkpoint Inhibitor
12%
Clinical Trial
12%
Neoplasm
12%
Immunotherapy
12%
Biological Marker
12%
Genomic DNA
12%